Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape. (2019)
Attributed to:
Tuberculosis Treatment Trials
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.pmed.1002767
PubMed Identifier: 30901331
Publication URI: http://europepmc.org/abstract/MED/30901331
Type: Journal Article/Review
Volume: 16
Parent Publication: PLoS medicine
Issue: 3
ISSN: 1549-1277